|
Antibe Therapeutics Inc. - Motion Materials
Revised Claims Procedure Order and Claims Procedure
Revised Claims Procedure Order and Claims Procedure (blackline)
|
June 24, 2024 |
|
This is a revised form of the Claims Procedure Order and Claims Procedure originally included in the Motion Record dated June 18, 2024. A blackline reflecting changes between the June 24, 2024 version of this document and the version of this document previously included with the Motion Record dated June 18, 2024 is included for reference.
|
|
Revised Claims Procedure Order and Claims Procedure
Revised Claims Procedure Order and Claims Procedure (blackline)
|
June 22, 2024 |
This is a revised form of the Claims Procedure Order and Claims Procedure originally included in the Motion Record dated June 18, 2024. A blackline reflecting changes between the June 22, 2024 version of this document and the version of this document previously included with the Motion Record dated June 18, 2024 is included for reference
|
|
Factum of the Receiver
|
June 22, 2024 |
This is a factum served in support of the Receiver's motion before the Honourable Justice Osborne of the Ontario Superior Court of Justice (Commercial List) on June 24, 2024 at 12:00 PM
|
|
Motion Record of the Receiver
|
June 18, 2024 |
The Receiver will make a motion before the Honourable Justice Osborne of the Ontario Superior Court of Justice (Commercial List) on June 24, 2024 at 12:00 PM for, inter alia:
(a) An order approving the Sale Process;
(b) An order approving the Claims Procedure; and
(c) An ancillary order:
(i) Approving the accounts of the Receiver and of its counsel, Thornton Grout Finnigan LLP;
(ii) Approving the activities and conduct of the Receiver and its counsel prior to the date hereof; and
(iii) Recognizing an Arbitral Award in favour of Nuance Pharma Ltd.
|
|
|
|